Diabetic Retinopathy

作者：David A. Antonetti, Ronald Klein, Thomas W. Gardner · 发表于：New England Journal of Medicine · 年份：2012 · DOI：10.1056/nejmra1005073 · 被引用次数：1633 · 研究领域：Retinal Diseases and Treatments、Retinal Imaging and Analysis、Advanced Glycation End Products research

The incidence of diabetes is increasing, but that of diabetic retinopathy is falling, probably owing to better management of glucose levels, lipid abnormalities, and hypertension. Clinical trials of VEGF and PPAR-α inhibitors are improving vision and providing insights into pathogenesis.